Labeler
Par Health USA, LLC NDC Codes
Par Health USA, LLC lists 216 finished drug products in the FDA NDC Directory under NDC labeler codes 0254, 10370, 42023, 49884.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexmethylphenidate Hydrochloride, Adrenalin (epinephrine in sodium chloride), Lamotrigine Extended-Release, Ephedrine Sulfate, Topiramate, Everolimus, Vasostrict, Sitagliptin and Metformin hydrochloride, Pitocin, Varenicline, sapropterin dihydrochloride, Nitisinone, Midodrine Hydrochloride, Sugammadex Sodium, Tiopronin
- Active ingredients
- Epinephrine, Dexmethylphenidate hydrochloride, Lamotrigine, Ephedrine sulfate, Topiramate, Everolimus, Vasopressin, Unspecified, Sitagliptin phosphate, Metformin hydrochloride, Oxytocin, Sapropterin dihydrochloride, Nitisinone
- NDC labeler codes
- 0254, 10370, 42023, 49884
- Strengths (from the 100 most recently listed products)
- Oxytocin 10 [iU]/mL; Metformin hydrochloride 1000 mg/1; Sitagliptin phosphate 50 mg/1; Ephedrine sulfate 5 mg/mL; Colchicine .6 mg/1; Vasopressin, Unspecified 20 [USP'U]/mL; Epinephrine 1 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Sapropterin dihydrochloride 100 mg/1; Penicillamine 250 mg/1; Phenylephrine hydrochloride 10 mg/mL; Ephedrine sulfate 50 mg/mL; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Sitagliptin phosphate 100 mg/1; Metformin hydrochloride 500 mg/1; Lamotrigine 100 mg/1; Lamotrigine 200 mg/1; Lamotrigine 300 mg/1; Lamotrigine 250 mg/1
- Dosage forms
- Injection, Tablet, Capsule, Extended release, Capsule, Tablet, Film coated, Tablet, Film coated, Extended release, Injection, Solution, Powder, For solution, Solution, Injection, Powder, Lyophilized, For solution, Tablet, Delayed release, Capsule, Delayed release, Capsule, Gelatin coated, Liquid, Kit, Suspension
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Sublingual
- Drug classes (FDA established)
- alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Catecholamine, Central Nervous System Stimulant, Anti-epileptic Agent, Mood Stabilizer, Norepinephrine Releasing Agent, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Biguanide, Dipeptidyl Peptidase 4 Inhibitor, Oxytocic, Nonsteroidal Anti-inflammatory Drug, Phenylalanine Hydroxylase Activator, 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor, Opioid Antagonist, Reducing and Complexing Thiol, Alkaloid, Proton Pump Inhibitor, Vasopressin V2 Receptor Antagonist, Cholinergic Receptor Agonist, Partial Cholinergic Nicotinic Agonist, Muscle Relaxant, Chloride Channel Activator, Central alpha-2 Adrenergic Agonist, Antirheumatic Agent, alpha-1 Adrenergic Agonist, Renin Inhibitor, gamma-Aminobutyric Acid A Receptor Positive Modulator, Cholinesterase Inhibitor, Platelet Aggregation Inhibitor, Lipopeptide Antibacterial, Nitrogen Binding Agent, Tetracycline-class Drug, Histamine-2 Receptor Antagonist, Anti-coagulant, Direct Thrombin Inhibitor, Bismuth, Nitroimidazole Antimicrobial, Tetracycline-class Antimicrobial, Azole Antifungal, Anticholinergic, Cholinergic Muscarinic Antagonist, Nitrate Vasodilator, Calcitonin, Antihistamine, Vitamin B6 Analog, Copper Chelator, Phenothiazine, Anthelmintic, Serotonin Reuptake Inhibitor, Antimetabolite Immunosuppressant, Angiotensin 2 Receptor Blocker, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Thiazide Diuretic
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 109 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Vareniclinevarenicline tartrate | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | 49884-156 | 49884-0156-76 | — |
| Vareniclinevarenicline tartrate | — | Kit | 49884-944 | 49884-0944-99 | — |
| Chlorzoxazone | Chlorzoxazone 375 mg/1 | TabletOral | 0254-2053 | 00254-2053-01 | — |
| Ephedrine Sulfate | Ephedrine sulfate 5 mg/mL | InjectionIntravenous | 42023-243 | 42023-0243-01 | — |
| Lubiprostone | Lubiprostone 8 ug/1 | Capsule, Gelatin coatedOral | 0254-3028 | 00254-3028-02 | — |
| Lubiprostone | Lubiprostone 24 ug/1 | Capsule, Gelatin coatedOral | 0254-3029 | 00254-3029-02 | — |
| Adrenalinepinephrine | Epinephrine 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 42023-168 | 42023-0168-89 | J0171 |
| Adrenalinepinephrine | Epinephrine 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 42023-168 | 42023-0168-99 | J0171 |
| Dexmedetomidine Hydrochloride | Dexmedetomidine hydrochloride 4 ug/mL | Injection, SolutionIntravenous | 42023-186 | 42023-0186-20 | — |
| Dexmedetomidine Hydrochloride | Dexmedetomidine hydrochloride 4 ug/mL | Injection, SolutionIntravenous | 42023-187 | 42023-0187-10 | — |
| Chlorzoxazone | Chlorzoxazone 750 mg/1 | TabletOral | 0254-2005 | 00254-2005-01 | — |
| sapropterin dihydrochloride | Sapropterin dihydrochloride 100 mg/1 | TabletOral | 49884-720 | 49884-0720-08 | — |
| Sapropterin Dihydrochloride | Sapropterin dihydrochloride 500 mg/1 | Powder, For solutionOral | 49884-873 | 49884-0873-72 | — |
| Sapropterin Dihydrochloride | Sapropterin dihydrochloride 100 mg/1 | Powder, For solutionOral | 49884-948 | 49884-0948-72 | — |
| Diazoxide | Diazoxide 50 mg/mL | SuspensionOral | 0254-1010 | 00254-1010-19 | — |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | 49884-146 | 49884-0146-01 | — |
| penicillamine | Penicillamine 250 mg/1 | Tablet, Film coatedOral | 0254-2000 | 00254-2000-01 | — |
| Doxylamine Succinate and Pyridoxine Hydrochloridedoxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg | Doxylamine succinate 10 mg/1; Pyridoxine hydrochloride 10 mg/1 | Tablet, Delayed releaseOral | 49884-186 | 49884-0186-01 | — |
| Nitisinone | Nitisinone 2 mg/1 | CapsuleOral | 0254-3020 | 00254-3020-02 | — |
| Nitisinone | Nitisinone 5 mg/1 | CapsuleOral | 0254-3021 | 00254-3021-02 | — |
| Nitisinone | Nitisinone 10 mg/1 | CapsuleOral | 0254-3022 | 00254-3022-02 | — |
| Trientine Hydrochloride | Trientine hydrochloride 250 mg/1 | CapsuleOral | 49884-060 | 49884-0060-01 | — |
| Phenylephrine hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 42023-214 | 42023-0214-10 | — |
| Phenylephrine hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 42023-215 | 42023-0215-01 | — |
| Aliskiren | Aliskiren hemifumarate 150 mg/1 | Tablet, Film coatedOral | 49884-424 | 49884-0424-11 | — |
| Aliskiren | Aliskiren hemifumarate 300 mg/1 | Tablet, Film coatedOral | 49884-425 | 49884-0425-11 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 49884-814 | 49884-0814-01 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 49884-849 | 49884-0849-01 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 49884-874 | 49884-0874-01 | — |
| Fluphenazine Decanoate | Fluphenazine decanoate 25 mg/mL | Injection, SolutionIntramuscular, Subcutaneous | 42023-129 | 42023-0129-89 | — |
| Ephedrine Sulfate | Ephedrine sulfate 50 mg/mL | Injection, SolutionIntravenous | 42023-216 | 42023-0216-83 | — |
| Pitocinoxytocin | Oxytocin 10 [iU]/mL | InjectionIntravenous | 42023-130 | 42023-0130-06 | — |
| Praziquantel | Praziquantel 600 mg/1 | Tablet, Film coatedOral | 49884-231 | 49884-0231-83 | — |
| Fluoxetine | Fluoxetine hydrochloride 60 mg/1 | Tablet, Film coatedOral | 49884-468 | 49884-0468-11 | — |
| Zolpidem tartrate sublingual | Zolpidem tartrate 1.75 mg/1 | TabletSublingual | 49884-898 | 49884-0898-11 | — |
| Zolpidem tartrate sublingual | Zolpidem tartrate 3.5 mg/1 | TabletSublingual | 49884-899 | 49884-0899-11 | — |
| Vigabatrin | Vigabatrin 50 mg/mL | Powder, For solutionOral | 49884-358 | 49884-0358-03 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate .5 mg/mL | InjectionIntravenous | 42023-188 | 42023-0188-10 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate 1 mg/mL | InjectionIntravenous | 42023-189 | 42023-0189-10 | — |
| Vasostrictvasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | 42023-190 | 42023-0190-01 | — |
| Ephedrine Sulfate | Ephedrine sulfate 50 mg/mL | Injection, SolutionIntravenous | 42023-216 | 42023-0216-25 | — |
| Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mgaspirin and extended - release dipyridamole | Aspirin 25 mg/1; Dipyridamole 200 mg/1 | CapsuleOral | 49884-007 | 49884-0007-02 | — |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 49884-049 | 49884-0049-01 | — |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | 49884-048 | 49884-0048-01 | — |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 49884-248 | 49884-0248-01 | — |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | 49884-333 | 49884-0333-01 | — |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | 49884-339 | 49884-0339-01 | — |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 49884-546 | 49884-0546-01 | — |
| Mycophenolate Mofetil | Mycophenolate mofetil 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 42023-172 | 42023-0172-04 | — |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Olmesartan medoxomil 20 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 49884-786 | 49884-0786-0949884-0786-11 | — |
Par Health USA, LLC: common questions
- What is Par Health USA, LLC's NDC labeler code?
- 0254, 10370, 42023, 49884. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Par Health USA, LLC?
- Med-Code's HCPCS directory matches J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.